Significance of breakpoint in the BCR gene in Ph+ALL

Significance of breakpoint in the BCR gene in Ph+ALL - Breakpoint of BCR in Ph+ALL

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030257

Enrollment

1500

Registered

2017-12-11

Start date

2017-12-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Philadelphia chromosome-positve acute lymphoblastic leukemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Ph+ALL patients who agreed the use of perserved samples 2. Ph+ALL patients who underwent allogeneic hematopoietic cell transplantation and whose data were registered in the TRUMP database

Exclusion criteria

Exclusion criteria: Patients who refused the use of their samples and/or data

Design outcomes

Primary

Measure	Time frame
Lineage of blood cells which expressed BCR-ABL chimeric gene	—

Countries

Japan

Contacts

Public ContactSatoshi Nishiwaki

Nagoya Univiersity Hospital Center for Advanced Medicine and Clinical Research

n-3104@med.nagoya-u.ac.jp052-744-2942

Outcome results